Sign in
Not yet taking people in United StatesPhase 2

Cannabidiol oil rubbed on the skin for knee osteoarthritis pain

Tests cannabidiol oil applied to the knee in people with knee osteoarthritis.

Key facts

Who runs it
University of Tennessee
Where
Memphis, United StatesSee the site
Trial code
Registry title
CBD Knee Osteoarthritis Study
Status
Not yet recruiting
Phase
Phase 2
People taking part
30 people, planned
Started
1 Jul 2026
Expected to end
30 Mar 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cannabidiol (CBD)
  • Castor Oil (Placebo)
Record updated
10 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with knee osteoarthritis pain who are treated at a Campbell Clinic Orthopaedics location. It tests CBD oil rubbed on the knee against castor oil alone.

Age
21 Years and older
Sex
All sexes can join.
Disease stage
Knee osteoarthritis grade 2-3 on the Kellgren-Lawrence scale, with knee pain above 4 on a pain scale in either knee.
Earlier treatment
People cannot join if they now use opioids, get knee injections (such as cortisol or hyaluronic acid gel), or use cannabis or CBD.

Main reasons for not taking part

  • Other types of arthritis, such as psoriatic or rheumatoid arthritis
  • BMI over 40, or needing a device such as a walker to walk
  • Knee replacement planned in the next 3-6 months
  • Pregnancy, breastfeeding or planning a pregnancy
  • Active chronic liver or kidney disease, active depression or suicidal thoughts, or more than 21 alcoholic drinks a week

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Knee OA (grade 2-3 as measured by the Kellgren-Lawrence Classification)
  • OA knee pain on the Visual Analog Pain Scale > 4 in either knee
  • Receiving treatment at one of the eight Campbell Clinic Orthopaedics locations

Who cannot take part

  • Those who are currently on knee injections (i.e. cortisol or hyaluronic acid gel) for knee pain
  • Medications that interact with CBD in the liver that cannot be discontinued 14. Discretion of the Multiple Principal Investigators for concerns regarding noncompliance with the study intervention
  • Other forms of arthritis such as psoriatic arthritis or rheumatoid arthritis due to different sources of inflammation in these conditions
  • Allergies to CBD or Castor Oil
  • Active chronic liver or renal disease
  • Current opioid use
  • BMI of over 40
  • Those who cannot walk without an assistance device (e.g., walker)
  • Patients scheduled for a knee replacement in the next 3-6 months
  • Active cannabis or CBD use
  • Alcohol consumption > 21 alcoholic drinks each week
  • Active pregnancy, nursing, or actively planning a pregnancy
  • Active depression/suicidality

Where in United States

  • University of Tennessee Health Science CenterMemphis, United StatesContact: Karen C Johnson, MD, MPH (principal investigator)Not yet recruiting

About the trial

What the trial wants to find out

Osteoarthritis of the knee is a common cause of pain in the US. The currently available medicines for knee osteoarthritis sometimes are not effective at relieving the pain or have unacceptable side effects. Thus, alternate pain relieving treatments are needed.

Read full original descriptionShow less

CBD, an active chemical from the hemp derived cannabis sativa plant, has received a lot of attention for its potential pain relieving properties, but there has been limited research to find out if topically applied CBD can decrease pain from knee osteoarthritis. CBD lacks the psychoactive effects seen with marijuana use, because it does not contain THC which is responsible for those effects in marijuana. It is legal to use CBD in the State of Tennessee (site of study).

The CBD Knee Study is sponsored by the University of Tennessee Health Science Center and is a collaborative effort between doctors at UT and Campbell Clinic. In the CBD Knee Study, the investigators are examining whether topically applied CBD dissolved in Castor Oil will relieve knee pain in persons with knee osteoarthritis.

Persons who take part in the study would need to come for study visits, fill out questionnaires about their health and knee pain, and would be asked to use the topical study oil on their knees. Taking part in the CBD Knee Study is voluntary.

The 2 groups in the trial

  • CBD+Castol OilExisting treatment, for comparison

    250 mg CBD dissolved in 1 ml of Castor Oil to be applied topically to the knee BID

    Treatment: Cannabidiol (CBD)

  • Castor Oil AlonePlacebo, for comparison

    1 ml of Castor Oil Alone applied topically to the knee as the placebo comparator BID

    Treatment: Castor Oil (Placebo)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Pilot Study Using Topical Cannabidiol (CBD) to Manage Osteoarthritic Knee Pain
Plain-language title
Cannabidiol oil rubbed on the skin for knee osteoarthritis painGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
10 June 2026